Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

All results

2 results for randomized double blind placebo controlled study assess efficacy safety and

  • REPLENISH

    The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52…

    Ages
    50 Years - N/A
    Sexes
    All
  • GCAptAIN

    This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…

    Ages
    50 Years - N/A
    Sexes
    All